Edges in Network
| Network | GSE16446_top500tf - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | MYC |
| Upstream (Parents) |
|---|
| (<<) TFAP2B → MYC |
| (<<) FOXA1 → MYC |
| (<<) FOXC1 → MYC |
| (<<) TFCP2L1 → MYC |
| (<<) SPDEF → MYC |
| (<<) TAF4B → MYC |
| (<<) CREB3L1 → MYC |
| (<<) PPARA → MYC |
| (<<) HOXD8 → MYC |
| Downstream (Children) |
|---|
| MYC → ZIC1 (>>) |
| MYC → ANKRD30A (>>) |
| MYC → HEY2 (>>) |
| MYC → MYCN (>>) |
| MYC → FOXM1 (>>) |
| MYC → HOXB6 (>>) |
| MYC → ETV1 (>>) |
| MYC → MSX2 (>>) |
| MYC → TCF7L1 (>>) |
| MYC → ASCL2 (>>) |
| MYC → ZNF91 (>>) |
| MYC → PCGF2 (>>) |
| MYC → E2F5 (>>) |
| MYC → HR (>>) |
| MYC → CSDA (>>) |
| MYC → LHX6 (>>) |
| MYC → ZFHX3 (>>) |
| MYC → IRX3 (>>) |
| MYC → TGIF2 (>>) |
| MYC → HMGA1 (>>) |
| MYC → HOXD1 (>>) |
| MYC → SCML2 (>>) |
| MYC → NOLC1 (>>) |
